← Back to Search

Radiation Therapy

Observation for Prostate Cancer

N/A
Recruiting
Research Sponsored by Linda Chan, MD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

Study Summary

This trial is testing the effectiveness of a new type of radiation therapy called TrueBeam in treating prostate cancer. The hope is that this new therapy will be more effective in treating the tumor while minimizing injury to nearby healthy tissue.

Eligible Conditions
  • Prostate Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Local control

Side effects data

From 2008 Phase 2 trial • 20 Patients • NCT00350142
15%
ulcer
10%
vomiting
5%
Perforation
5%
pain
100%
80%
60%
40%
20%
0%
Study treatment Arm
SBRT With Gem

Trial Design

1Treatment groups
Experimental Treatment
Group I: ObservationExperimental Treatment1 Intervention
Observational study of patient efficacy and side effects
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Stereotactic Body Radiotherapy
2017
Completed Phase 2
~220

Find a Location

Who is running the clinical trial?

Linda Chan, MDLead Sponsor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available vacancies for this research endeavor?

"Data accessible on clinicaltrials.gov reports that this trial is in its recruitment stage, with the first post being made on June 5th 2018 and the last update taking place November 3rd 2022."

Answered by AI

What is the current cohort size of this research study?

"Affirmative. Clinicaltrials.gov's data suggests that this research endeavor, which was initially posted on June 5th 2018, is currently soliciting participants. Approximately 167 individuals must be recruited from a single center."

Answered by AI
~25 spots leftby Mar 2025